Karin Walker
Directeur/Bestuurslid bij CYCLACEL PHARMACEUTICALS, INC.
Vermogen: 6 696 $ op 30-04-2024
Actieve functies van Karin Walker
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| PROTHENA CORPORATION PLC | Comptroller/Controller/Auditor | 20-05-2013 | - |
| CYCLACEL PHARMACEUTICALS, INC. | Directeur/Bestuurslid | 09-11-2020 | - |
| Independent Dir/Board Member | 09-11-2020 | - |
Loopbaan van Karin Walker
Eerdere bekende functies van Karin Walker
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| VINCERX PHARMA, INC. | Directeur/Bestuurslid | 05-03-2020 | 23-12-2020 |
| Independent Dir/Board Member | 05-03-2020 | 23-12-2020 | |
| AFFYMAX, INC. | Comptroller/Controller/Auditor | 02-10-2012 | 01-05-2013 |
| AMYRIS, INC. | Comptroller/Controller/Auditor | 01-01-2009 | 01-01-2012 |
CV Therapeutics, Inc.
 CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Comptroller/Controller/Auditor | 01-01-2006 | 01-01-2009 |
Ernst & Young US LLP
 Ernst & Young US LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young US LLP was engaged in providing accounting services. The company was headquartered in Pittsburgh, PA. | Corporate Officer/Principal | - | - |
Opleiding van Karin Walker
| California Polytechnic State University (San Luis Obispo) | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 8 |
| Ierland | 2 |
Operationeel
| Comptroller/Controller/Auditor | 4 |
| Director/Board Member | 2 |
| Independent Dir/Board Member | 2 |
Sectoraal
| Health Technology | 5 |
| Process Industries | 2 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 4 |
|---|---|
| AMYRIS, INC. | Process Industries |
| AFFYMAX, INC. | Health Technology |
| CYCLACEL PHARMACEUTICALS, INC. | Health Technology |
| PROTHENA CORPORATION PLC | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Health Technology |
Ernst & Young US LLP
Ernst & Young US LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young US LLP was engaged in providing accounting services. The company was headquartered in Pittsburgh, PA. | Commercial Services |
LifeSci Acquisition Corp.
 LifeSci Acquisition Corp. Financial ConglomeratesFinance LifeSci Acquisition Corp. operates as a blank check company. It was formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities. The company was founded on December 19, 2018 and is headquartered in New York, NY. | Finance |
- Beurs
- Insiders
- Karin Walker
- Ervaring
